Haihe Pharmaceutical

Haihe Pharmaceutical focuses on discovery, development and commercialization of innovative anti-tumor drugs. Led by an academician of the Chinese Academy of Engineering and a senior management team with extensive experience in drug research and development in China and abroad, Haihe Pharmaceutical has built a precision medical platform guided by biomarkers. The company has also built a fully integrated pre-clinical evaluation technical platform and clinical study system for innovative drugs, with advanced technology and operation in consistence with international standards and norms, covering subunits from compound synthesis, CMC study, biomarker discovery and validation, medical strategy and clinical study, etc. With a globally competitive innovative drug R&D system, the company has a robust product pipeline, including 8 compounds in clinical and 3 compounds in preclinical studies.